JP2007534737A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007534737A5 JP2007534737A5 JP2007510131A JP2007510131A JP2007534737A5 JP 2007534737 A5 JP2007534737 A5 JP 2007534737A5 JP 2007510131 A JP2007510131 A JP 2007510131A JP 2007510131 A JP2007510131 A JP 2007510131A JP 2007534737 A5 JP2007534737 A5 JP 2007534737A5
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- alkyl
- methine
- carbon atoms
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 239000007795 chemical reaction product Substances 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000003495 polar organic solvent Substances 0.000 claims 3
- 239000000047 product Substances 0.000 claims 3
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims 3
- JJTNLWSCFYERCK-UHFFFAOYSA-N 7h-pyrrolo[2,3-d]pyrimidine Chemical class N1=CN=C2NC=CC2=C1 JJTNLWSCFYERCK-UHFFFAOYSA-N 0.000 claims 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 150000002429 hydrazines Chemical class 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- -1 nitro, amino Chemical group 0.000 claims 2
- 239000012074 organic phase Substances 0.000 claims 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 238000010992 reflux Methods 0.000 claims 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 208000004454 Hyperalgesia Diseases 0.000 claims 1
- 208000035154 Hyperesthesia Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 230000001760 anti-analgesic effect Effects 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 239000000010 aprotic solvent Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 claims 1
- 239000005457 ice water Substances 0.000 claims 1
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 claims 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims 1
- 230000002981 neuropathic effect Effects 0.000 claims 1
- 125000002560 nitrile group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000012454 non-polar solvent Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400891A HUP0400891A2 (en) | 2004-04-29 | 2004-04-29 | 7h-pyrrolo[2,3-d]pyrimidine derivatives, their pharmaceutically acceptable salts, pharmaceutical compositions containing them and process for the production of the compounds |
| PCT/HU2005/000040 WO2005105804A1 (en) | 2004-04-29 | 2005-04-25 | 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007534737A JP2007534737A (ja) | 2007-11-29 |
| JP2007534737A5 true JP2007534737A5 (enExample) | 2008-06-19 |
Family
ID=89982174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007510131A Withdrawn JP2007534737A (ja) | 2004-04-29 | 2005-04-25 | ７Ｈ−ピロロ［２，３−ｄ］ピリミジン誘導体、ならびにその治療的に許容される塩、それらを含有する製薬調製物および活性剤を生成するプロセス |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080214583A1 (enExample) |
| EP (1) | EP1756110B1 (enExample) |
| JP (1) | JP2007534737A (enExample) |
| KR (1) | KR20070047737A (enExample) |
| CN (1) | CN1972946A (enExample) |
| AT (1) | ATE462706T1 (enExample) |
| AU (1) | AU2005238287A1 (enExample) |
| CA (1) | CA2564277A1 (enExample) |
| DE (1) | DE602005020281D1 (enExample) |
| HU (1) | HUP0400891A2 (enExample) |
| IL (1) | IL178906A0 (enExample) |
| RU (1) | RU2391344C2 (enExample) |
| WO (1) | WO2005105804A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2852593A1 (en) * | 2012-05-21 | 2015-04-01 | Bayer Pharma Aktiengesellschaft | Substituted pyrrolopyrimidines |
| WO2014145576A2 (en) * | 2013-03-15 | 2014-09-18 | Northwestern University | Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer |
| EP3194399B1 (en) * | 2014-09-17 | 2019-04-10 | Pécsi Tudományegyetem | New agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders |
| RU2603770C2 (ru) * | 2014-11-28 | 2016-11-27 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Замещенные пиразинопиримидиноны как блокаторы trpa1 каналов, фармацевтическая композиция, способы их получения и применения |
| CN110483526B (zh) * | 2019-09-09 | 2021-10-01 | 辽宁大学 | 含芳基腙结构的吡唑并[1,5-a]嘧啶类衍生物及其应用 |
| CN119613409A (zh) * | 2024-12-05 | 2025-03-14 | 浙江工业大学 | 吡咯并[2,3-d]嘧啶衍生物及其在制备抗炎药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2818676A1 (de) * | 1978-04-27 | 1979-11-08 | Troponwerke Gmbh & Co Kg | Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| ATE236166T1 (de) * | 1998-05-19 | 2003-04-15 | Otsuka Pharma Co Ltd | Pyrazolo(1,5-a)pyrimidine |
| RU2001111033A (ru) * | 1998-09-18 | 2003-05-20 | Басф Акциенгезелльшафт (De) | Пирролопиримидины в качестве ингибиторов протеинкиназ |
| GEP20053479B (en) * | 1999-12-10 | 2005-03-25 | Pfizer Prod Inc | Pyrrolo[2,3-d]Pyrimidine Compounds, Pharmaceutical Composition Containing the Same and Use |
| WO2006017443A2 (en) * | 2004-08-02 | 2006-02-16 | Osi Pharmaceuticals, Inc. | Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
-
2004
- 2004-04-29 HU HU0400891A patent/HUP0400891A2/hu unknown
-
2005
- 2005-04-25 JP JP2007510131A patent/JP2007534737A/ja not_active Withdrawn
- 2005-04-25 DE DE602005020281T patent/DE602005020281D1/de not_active Expired - Fee Related
- 2005-04-25 CA CA002564277A patent/CA2564277A1/en not_active Abandoned
- 2005-04-25 WO PCT/HU2005/000040 patent/WO2005105804A1/en not_active Ceased
- 2005-04-25 RU RU2006141393/04A patent/RU2391344C2/ru not_active IP Right Cessation
- 2005-04-25 EP EP05739554A patent/EP1756110B1/en not_active Expired - Lifetime
- 2005-04-25 KR KR1020067025009A patent/KR20070047737A/ko not_active Ceased
- 2005-04-25 CN CNA2005800206893A patent/CN1972946A/zh active Pending
- 2005-04-25 US US11/587,851 patent/US20080214583A1/en not_active Abandoned
- 2005-04-25 AU AU2005238287A patent/AU2005238287A1/en not_active Abandoned
- 2005-04-25 AT AT05739554T patent/ATE462706T1/de not_active IP Right Cessation
-
2006
- 2006-10-26 IL IL178906A patent/IL178906A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2812363C (en) | Substituted polycyclic carbamoyl pyridone derivative prodrug | |
| US20090192200A1 (en) | Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof | |
| CA2429309A1 (en) | Novel carbamate-substituted pyrazolopyridine derivatives | |
| JP2014518886A (ja) | 関節炎の治療に有用な新規イミダゾール誘導体 | |
| CN104356072A (zh) | 5-氟尿嘧啶药物共晶及其制备方法 | |
| JPH03502573A (ja) | 抗癌剤としての置換キナゾリノン | |
| CN103601670B (zh) | 荜拔酰胺类似物及其制备方法与应用 | |
| CA2429313A1 (en) | Novel sulfonamide-substituted pyrazolopyridine derivatives | |
| WO2014005443A1 (zh) | 一种制备选择性抗凝血药替卡格雷及其中间体的方法 | |
| JP2006516653A (ja) | キナーゼ阻害剤ピロロトリアジンの製造方法 | |
| NZ521069A (en) | Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines | |
| PT888316E (pt) | Derivados de 2-(3h)-oxazolona e sua utilizacao como inibidores de cox-2 | |
| CA2730079A1 (en) | Processes for the preparation of crystalline forms of sunitinib malate | |
| JP2007534737A5 (enExample) | ||
| JPS582948B2 (ja) | コウウイルスセイチカン １ ３− ジメチル −１ｈ− ピラゾロ （ ３，４ｄ ） キノリンルイ | |
| CN103360398A (zh) | 一种三唑并嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用 | |
| CN101003548B (zh) | 松香基二萜改性α-氨基磷酸酯、制备方法及抗肿瘤应用 | |
| RU2391344C2 (ru) | ПРОИЗВОДНЫЕ 7Н-ПИРРОЛ[2,3-d]ПИРИМИДИНА, ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБ ИХ ПОЛУЧЕНИЯ | |
| JP5785622B2 (ja) | その構造内にグルタミン酸部分を有する葉酸拮抗薬の新規な製造方法 | |
| CN103025734A (zh) | 制备化合物osi-906的方法 | |
| CN110204559B (zh) | 一种含咔唑基三唑并噻二唑衍生物及其制备方法 | |
| AU2012322750B2 (en) | 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances | |
| US7148222B2 (en) | Substituted pyrido-pyridazine derivatives which enhance cognition via the GABA-A receptors | |
| CN102666527B (zh) | 5-(2-氨基-嘧啶-4-基)-2-芳基-1h-吡咯-3-甲酰胺的制备方法 | |
| CN103119040A (zh) | 制备利奈唑胺的方法 |